Skip to content

Clinical trials

Observational Diabetes Mellitus trials in Tunisia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Observational Country / region: Tunisia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20101
20111
20121
20161
20201
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
University of Monastir2
Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose1
Dacima Consulting1
Mongi Slim Hospital1
National Cancer Institute (NCI)1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sana Rouis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus11
Diabetes Mellitus, Type 23
Hypertension3
Dyslipidemias2
Atherosclerosis1
COVID-191
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1
Death1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.